Por favor, use este identificador para citar o enlazar este ítem: https://repositorio.unifesp.br/xmlui/handle/11600/62312
Título : The current drug discovery landscape for trypanosomiasis and leishmaniasis: challenges and strategies to identify drug targets
Autor : Altamura, Fernando
Rajesh, Rishi
Catta-Preta, Carolina M. C.
Moretti, Nilmar Silvio [UNIFESP]
Cestari, Igor
http://lattes.cnpq.br/2131472726202687
Palabras clave : Clinical trial
CRISPR-Cas9 systems
Drug discovery
Leishmaniasis
Leglected diseases
Trypanosomiasis
Fecha de publicación : 2020
Editorial : Willey Periodicals
Resumen : Human trypanosomiasis and leishmaniasis are vector-borne neglected tropical diseases caused by infection with the protozoan parasites Trypanosoma spp. and Leishmania spp., respectively. Once restricted to endemic areas, these diseases are now distributed worldwide due to human migration, climate change, and anthropogenic disturbance, causing significant health and economic burden globally. The current chemotherapy used to treat these diseases has limited efficacy, and drug resistance is spreading. Hence, new drugs are urgently needed. Phenotypic compound screenings have pre- vailed as the leading method to discover new drug candidates against these diseases. However, the publication of the complete genome sequences of multiple strains, advances in the application of CRISPR/Cas9 technology, and in vivo bioluminescence- based imaging have set the stage for advancing target-based drug discovery. This review analyses the limitations of the narrow pool of available drugs presently used for treating these diseases. It describes the current drug-based clinical trials highlighting the most promising leads. Furthermore, the review presents a focused discussion on the most important biological and pharmacological challenges that target-based drug discovery programs must overcome to advance drug candidates. Finally, it examines the advantages and limitations of modern research tools designed to identify and vali- date essential genes as drug targets, including genomic editing applications and in vivo imaging.
URI : https://repositorio.unifesp.br/xmlui/handle/11600/62312
Aparece en las colecciones: EPM - Artigos

Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
Altamura et al 2020.pdf
  Until 2030-01-01
Artigo Principal1.58 MBAdobe PDFVisualizar/Abrir  Request a copy


Los ítems de DSpace están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.